GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CellaVision AB (OSTO:CEVI) » Definitions » Short Interest

CellaVision AB (OSTO:CEVI) Short Interest


View and export this data going back to 2007. Start your Free Trial

What is CellaVision AB Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of CellaVision AB's Short Interest

For the Medical Devices subindustry, CellaVision AB's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CellaVision AB's Short Interest Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CellaVision AB's Short Interest distribution charts can be found below:

* The bar in red indicates where CellaVision AB's Short Interest falls into.


;
;

CellaVision AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CellaVision AB (OSTO:CEVI) » Definitions » Short Interest
Comparable Companies
OSTO:MCAP OSTO:BICO OSTO:PAX OSTO:OSSD OSTO:BACTI B OSTO:CRAD B OSTO:SEDANA OSTO:SEZI OSTO:MNTC OSTO:PRO ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM XAMS:PHIA ZBH
Traded in Other Exchanges
0MR5:UK CEVIs:UK C26:Germany
Address
Mobilvagen 12, Lund, SWE, 22362
Website
https://www.cellavision.com
CellaVision AB is engaged in the business of supplying digital solutions for blood and body fluid analysis. Its solutions are based on digital image analysis technology, artificial intelligence, and information technology. The firm's product portfolio consists of CellaVision peripheral blood application, CellaVision advanced RBC application, and CellaVision remote review software. Its customers include mainly large hospital laboratories and commercial laboratories in North America, Europe and China, and Japan. The company derives the majority of its revenue from the sale of analyzers or software.

CellaVision AB Headlines

No Headlines